04.03.2014 Views

Classical and augmentative biological control against ... - IOBC-WPRS

Classical and augmentative biological control against ... - IOBC-WPRS

Classical and augmentative biological control against ... - IOBC-WPRS

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Chapter 5<br />

Identified difficulties <strong>and</strong> conditions for field success of bio<strong>control</strong>.<br />

1. Regulatory aspects<br />

Ulf Heilig 1 , Claude Alabouvette 2* <strong>and</strong> Bernard Blum 1<br />

1 International Bio<strong>control</strong> Manufacturers Association, Blauenstrasse 57, CH-4054 Basel,<br />

Switzerl<strong>and</strong><br />

2 INRA, UMR1229, Microbiologie du Sol et de l'Environnement, 17 rue Sully, F -21000 Dijon,<br />

France<br />

Objectives<br />

The objective of the work was to identify typical hurdles for the placing of <strong>biological</strong> plant<br />

protection products on the market experienced by bio<strong>control</strong> industry or evaluators in the recent<br />

past under the European directive 91/414/EEC. In parallel, we examined the new regulation (No<br />

1107/2009/EC of the European Parliament <strong>and</strong> of the Council of 21 October 2009) concerning the<br />

placing of plant protection products on the market <strong>and</strong> repealing Council Directives 79/117/EEC<br />

<strong>and</strong> 91/414/EEC <strong>and</strong> the new directive (N° 2009/128/EC of the European Parliament <strong>and</strong> of the<br />

Council of 21 October 2009) establishing a framework for Community action to achieve the<br />

sustainable use of pesticides. These two texts were examined for provisions creating new<br />

opportunities for the approval bio<strong>control</strong> agents, their placing on the market <strong>and</strong> use. In fine, it was<br />

the intent to establish a dialogue with EU regulators <strong>and</strong> evaluators in European institutions, i.e. in<br />

the European Commission <strong>and</strong> in the European Food Safety Agency (EFSA) <strong>and</strong> to seek solutions<br />

in common for the problems encountered.<br />

Working method<br />

An ad hoc group of representatives from the bio<strong>control</strong> industry <strong>and</strong> INRA called "Regulatory<br />

Review Team" was set up. Two full-day working sessions were organised in which regulatory<br />

experts identified difficulties <strong>and</strong> questions but also described positive experience <strong>and</strong> perspectives.<br />

The work of the Regulatory Review Team active under Reasearch Activity RA4.3 of the<br />

ENDURE network was then summarised <strong>and</strong> reported in a meeting of a delegation of ENDURE<br />

partners (IBMA, INRA <strong>and</strong> ACTA) with representatives of the European Commission (DG<br />

SANCO, DG Agriculture, DG Research) <strong>and</strong> the EFSA in Brussels (24 September 2009).<br />

Results<br />

A PowerPoint presentation entitled "Gaps - Problems - Opportunities for BCAs in E.U.<br />

Regulation - From Past to Future" was prepared for the ENDURE – Commission meeting, with<br />

inputs on general regulatory issues, micro-organisms, straight chain lepidopteran pheromones <strong>and</strong><br />

botanicals. In this document, two key issues related to directive 2001/36/EC annex II B which fixed<br />

requirements for microbial active substances were highlighted. Readers may note that since 14 th<br />

June 2011 Regulation (EU) No 544/2011 implements these data requirements unchanged to reg.<br />

* Current address: AGRENE, 47 rue Constant Pierrot 21000 DIJON, c.ala@agrene.fr<br />

42

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!